Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study
- PMID: 28521824
- PMCID: PMC5437558
- DOI: 10.1186/s13075-017-1315-z
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study
Abstract
Background: To investigate the risk of first-time acute coronary syndrome (ACS), stroke and venous thromboembolism (VTE) in patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated spondyloarthritis (uSpA), compared to each other and to the general population (GP).
Methods: This is a prospective nationwide cohort study. Cohorts with AS (n = 6448), PsA (n = 16,063) and uSpA (n = 5190) patients and a GP (n = 266,435) cohort, were identified 2001-2009 in the Swedish National Patient and Population registers. The follow-up began 1 January 2006, or 6 months after the first registered spondyloarthritis (SpA) diagnosis thereafter, and ended at ACS/stroke/VTE event, death, emigration or 31 December 2012. Crude and age- and sex-standardized incidence rates (SIRs) and hazard ratios (HRs) were calculated for incident ACS, stroke or VTE, respectively.
Results: Standardized to the GP cohort, SIRs for ACS were 4.3, 5.4 and 4.7 events per 1000 person-years at risk in the AS, PsA and uSpA cohort, respectively, compared to 3.2 in the GP cohort. SIRs for stroke were 5.4, 5.9 and 5.7 events per 1000 person-years at risk in the AS, PsA and uSpA cohort compared to 4.7 in the GP cohort. Corresponding SIRs for VTE were 3.6, 3.2 and 3.5 events per 1000 person-years at risk compared to 2.2 in the GP cohort. Age-and sex-adjusted HRs (95% CI) for ACS events were significantly increased in AS (1.54 (1.31-1.82)), PsA (1.76 (1.59-1.95)) and uSpA (1.36 (1.05-1.76)) compared to GP. Age-adjusted HRs for ACS was significantly decreased in female AS patients (0.59 (0.37-0.97)) compared to female PsA patients. Age-and sex-adjusted HRs for stroke events were significantly increased in AS (1.25 (1.06-1.48)) and PsA (1.34 (1.22-1.48)), and nonsignificantly increased in uSpA (1.16 (0.91-1.47)) compared to GP. For VTE the age-and sex-adjusted HRs for AS, PsA and uSpA were equally and significantly increased with about 50% compared to GP.
Conclusions: Patients with AS, PsA and uSpA are at increased risk for ACS and stroke events, which emphasizes the importance of identification of and intervention against cardiovascular risk factors in SpA patients. Increased alertness for VTE is warranted in patients with SpA.
Keywords: Acute coronary syndrome; Ankylosing spondylitis; Cardiovascular disease; Cohort; Psoriatic arthritis; Spondylarthropathies; Spondyloarthritis; Stroke; Undifferentiated spondyloarthritis; Venous thromboembolism.
Figures
Similar articles
-
Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden.Ann Rheum Dis. 2018 Apr;77(4):541-548. doi: 10.1136/annrheumdis-2017-212189. Epub 2017 Dec 19. Ann Rheum Dis. 2018. PMID: 29259045
-
Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.Rheumatology (Oxford). 2013 Oct;52(10):1873-8. doi: 10.1093/rheumatology/ket239. Epub 2013 Jul 16. Rheumatology (Oxford). 2013. PMID: 23861532
-
Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study.Rheumatology (Oxford). 2021 Jun 18;60(6):2725-2734. doi: 10.1093/rheumatology/keaa692. Rheumatology (Oxford). 2021. PMID: 33216939 Free PMC article.
-
Role of comorbidities in spondyloarthritis including psoriatic arthritis.Clin Rheumatol. 2019 Jan;38(1):3-10. doi: 10.1007/s10067-018-4332-7. Epub 2018 Oct 18. Clin Rheumatol. 2019. PMID: 30338414 Review.
-
Psoriatic Spondylitis: A Disease Manifestation in Debate: Evidences to Know for the Clinical Rheumatologist.J Clin Rheumatol. 2022 Jan 1;28(1):38-43. doi: 10.1097/RHU.0000000000001815. J Clin Rheumatol. 2022. PMID: 34941618 Review.
Cited by
-
The prevalence of chronic obstructive pulmonary disease in patients with spondyloarthritis compared to the general population in the southernmost region of Sweden: a case-control study.Clin Exp Med. 2024 Apr 10;24(1):75. doi: 10.1007/s10238-024-01335-x. Clin Exp Med. 2024. PMID: 38598034 Free PMC article.
-
Increased carotid intima-media thickness in patients with radiographic axial spondyloarthritis compared to controls and associations with markers of inflammation.Clin Rheumatol. 2024 May;43(5):1559-1570. doi: 10.1007/s10067-024-06913-8. Epub 2024 Mar 6. Clin Rheumatol. 2024. PMID: 38443604 Free PMC article.
-
Pakistani Ankylosing Spondylitis Cohort with modifiable cardiovascular risk factors (PAS-CVD) study.Pak J Med Sci. 2024 Jan-Feb;40(3Part-II):438-443. doi: 10.12669/pjms.40.3.7265. Pak J Med Sci. 2024. PMID: 38356840 Free PMC article.
-
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.Arthritis Res Ther. 2024 Feb 12;26(1):49. doi: 10.1186/s13075-023-03257-7. Arthritis Res Ther. 2024. PMID: 38347650 Free PMC article.
-
Comorbidities Burden and Implementation of the Treat-to-Target Strategy in Predicting Real-World Patient Outcomes in Spondyloarthritides.Mediterr J Rheumatol. 2023 Jul 31;34(4):581-587. doi: 10.31138/mjr.310723.cba. eCollection 2023 Dec. Mediterr J Rheumatol. 2023. PMID: 38282943 Free PMC article.
References
-
- Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17–28. doi: 10.1136/annrheumdis-2016-209775. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous